1-(5-fluoropyrimidin-2-yl)-4-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine

Catalog No. :
ACVCSB126
CAS No. :
2097603-71-7
Molecular Formula :
C10H11FN6
Molecular Weight :
234.24

IUPAC Name:1-(5-fluoropyrimidin-2-yl)-4-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine

1-(5-fluoropyrimidin-2-yl)-4-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g97%$2356.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name1-(5-fluoropyrimidin-2-yl)-4-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine
IUPAC Name1-(5-fluoropyrimidin-2-yl)-4-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine
Molecular FormulaC10H11FN6
Molecular Weight234.24
SMILESCC1C2=C(N(C3=NC=C(F)C=N3)N=N2)CCN1
InChI KeyWOWPPQKCNFAUJQ-UHFFFAOYSA-N
Synonym1-(5-fluoropyrimidin-2-yl)-4-methyl-4,5,6,7-tetrahydro-1H-[1,2,3]triazolo[4,5-c]pyridine;1H-1,2,3-Triazolo[4,5-c]pyridine, 1-(5-fluoro-2-pyrimidinyl)-4,5,6,7-tetrahydro-4-methyl-
CAS No.2097603-71-7

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACVCSB126 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACVCSB126 route product structure diagram
    ACVCSB1262097603-71-7
Inquiry

2. ACVCSB126 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACXFEN753 route compound structure diagram
    ACXFEN75362802-42-0 In Stock
  4. Then
  5. ACVCSB126 route product structure diagram
    ACVCSB1262097603-71-7
Inquiry

Comments (0)